Search hospitals > Ohio > Akron

Children's Hospital Medical Center of Akron

Claim this profile
Akron, Ohio 44308
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoma
Conducts research for Brain Tumor
208 reported clinical trials
5 medical researchers
Photo of Children's Hospital Medical Center of Akron in AkronPhoto of Children's Hospital Medical Center of Akron in AkronPhoto of Children's Hospital Medical Center of Akron in Akron

Summary

Children's Hospital Medical Center of Akron is a medical facility located in Akron, Ohio. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma, Brain Tumor and other specialties. Children's Hospital Medical Center of Akron is involved with conducting 208 clinical trials across 392 conditions. There are 5 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Ryan Nofziger, MD.

Area of expertise

1Leukemia
Global Leader
Children's Hospital Medical Center of Akron has run 53 trials for Leukemia. Some of their research focus areas include:
Philadelphia chromosome positive
Stage II
NTRK1 positive
2Tumors
Global Leader
Children's Hospital Medical Center of Akron has run 39 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Children's Hospital Medical Center of Akron

Acute Lymphoblastic Leukemia
Rhabdomyosarcoma
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Astrocytoma
Leukemia
Acute Leukemia
Lymphoma
Lymphoblastic Leukemia-Lymphoma
Image of trial facility.

Imatinib + Chemotherapy

for Acute Lymphoblastic Leukemia

This study is evaluating whether a combination of drugs may help treat patients with a specific type of leukemia.
Recruiting2 awards Phase 3
Image of trial facility.

Levocarnitine

for Chemotherapy-Related Liver Protection in Leukemia and Lymphoma

This phase III trial compares the effect of adding levocarnitine to standard chemotherapy vs. standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for the treatment of acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), and mixed phenotype acute leukemia (MPAL). However, in adolescent and young adults (AYA) ages 15-39 years, liver toxicity from asparaginase is common and often prevents delivery of planned chemotherapy, thereby potentially compromising outcomes. Some groups of people may also be at higher risk for liver damage due to the presence of fat in the liver even before starting chemotherapy. Patients who are of Japanese descent, Native Hawaiian, Hispanic or Latinx may be at greater risk for liver damage from chemotherapy for this reason. Carnitine is a naturally occurring nutrient that is part of a typical diet and is also made by the body. Carnitine is necessary for metabolism and its deficiency or absence is associated with liver and other organ damage. Levocarnitine is a drug used to provide extra carnitine. Laboratory and real-world usage of the dietary supplement levocarnitine suggests its potential to prevent or reduce liver toxicity from asparaginase. The overall goal of this study is to determine whether adding levocarnitine to standard of care chemotherapy will reduce the chance of developing severe liver damage from asparaginase chemotherapy in ALL, LL and/or MPAL patients.
Recruiting2 awards Phase 3
Image of trial facility.

Blinatumomab + Chemotherapy

for Leukemia

This study is evaluating whether a combination of chemotherapy and a monoclonal antibody may be more effective than chemotherapy alone in treating patients with B-lymphoblastic leukemia or B-ly
Recruiting2 awards Phase 36 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Hospital Medical Center of Akron?
Children's Hospital Medical Center of Akron is a medical facility located in Akron, Ohio. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma, Brain Tumor and other specialties. Children's Hospital Medical Center of Akron is involved with conducting 208 clinical trials across 392 conditions. There are 5 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Ryan Nofziger, MD.